Skip to main content

Table 3 Acute toxicity during radio (chemo)therapy (all patients, patients with PTV ≤ 110 ml and patients with PTV > 110 ml)

From: Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort

 

All patients (n = 64)

PTV ≤ 110 ml (n = 32)

PTV > 110 ml (n = 32)

Headache (≤ II° CTC)

7/64 (10.9%)

2/32 (6.3%)

5/32 (15.6%)

Nausea/vomiting (≤ II° CTC)

4/64 (6.3%)

3/32 (9.3%)

1/32 (3.1%)

Seizures (≤ II° CTC)

5/64 (7.8%)

2/32 (6.2%)

3/32 (9.3%)

Skin reaction (≤ II° CTC)

7/64 (10.9%)

3/32 (9.3%)

4/32 (12.5%)

Mucosa reaction (≤ II° CTC)

2/64 (3.1%)

1/32 (3.1%)

1/32 (3.1%)

Ear toxicity (≤ II° CTC)

0/64 (0%)

0/64 (0%)

0/64 (0%)

Infections (≤ II° CTC)

3/64 (4.6%)

1/32 (3.1%)

2/32 (6.3%)

  1. PTV planned target volume, CTC common toxicity criteria version 3.0.